<rss version="2.0" xmlns:a10="http://www.w3.org/2005/Atom"><channel><title>RSC - RSC Med. Chem. latest articles</title><link>http://pubs.rsc.org/en/Journals/Journal/MD</link><description>RSC - RSC Med. Chem. latest articles</description><copyright>Copyright (c)  The Royal Society of Chemistry</copyright><lastBuildDate>Wed, 15 Apr 2026 05:56:51 Z</lastBuildDate><category>RSC - RSC Med. Chem. latest articles</category><image><url>http://pubs.rsc.org/content/NewImages/rsc_publishing_logo.gif</url><title>RSC - RSC Med. Chem. latest articles</title><link>http://pubs.rsc.org/en/Journals/Journal/MD</link></image><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00023A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00023A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00023A</link><title>Recent Advances in the Development of Acridine-Based Hybrids with Antiproliferative Activity</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00023A, Review Article&lt;/div&gt;&lt;div&gt;Mahdi Gallala, Najeh  Tka, Sonia  Aroui&lt;br/&gt;Cancer remains a leading cause of mortality worldwide, with the limitations of conventional singletarget therapies, such as severe side effects and drug resistance, driving the need for innovative treatment strategies....&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-14T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Mahdi Gallala</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Najeh  Tka</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sonia  Aroui</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00911A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00911A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00911A</link><title>Hypoxia-triggered dichloroacetate delivery with effective reversal of cancer cell reprogramming</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00911A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00911A, Research Article&lt;/div&gt;&lt;div&gt;Rensong Sun, Lei Wang, Ziang Liu, Hao Wu, Wanwan Wang, Yang Wang, Xiao Qian, Engin U. Akkaya&lt;br/&gt;The 3-methyl-2-nitroimidazole dichloroacetate derivative studied in this work is a prodrug version of dichloroacetate, and it is active at lower concentrations in hypoxic cell cultures and suppresses tumor progression significantly &lt;em&gt;in vivo&lt;/em&gt;.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-02T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Rensong Sun</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lei Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ziang Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hao Wu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wanwan Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yang Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xiao Qian</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Engin U. Akkaya</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00819K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00819K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00819K</link><title>Decoding the association of polycystic ovary syndrome with metabolic-associated fatty liver: insights into CK18 and LC3II/ATG7/P62 autophagy axis and adjunct therapeutics of metformin and levothyroxine</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00819K" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00819K, Research Article&lt;/div&gt;&lt;div&gt;Sameeah Mejbel Hamad Algenabi, Anwar Nather Seiwan, Maha Hussein Hashem Sabra, Doaa I. Mohamed, Lobna Fouad Abd ElAziz Bassyouni, Dalia Alaa El-Din Aly El-Waseef, Samar F. Ezzat, Omnyah A. El-Kharashi, Hanaa F. Abd El-Kareem, Hyfa A. Alzahrani, Fawzyah Obeedallah Albaldi, Ahmed Shokry Elharoun, Mansour Altayyar, Amal Fahmy Dawood, Hebatallah H. Abo Nahas, Ahmed Abdel-Salam M. Elmelegy&lt;br/&gt;Metformin–levothyroxine synergistically treats PCOS-MAFLD. Reduced body/liver weight, ALT/AST/TSH/lipids, testosterone/LH/HOMA-IR. Increased estradiol. Suppressed autophagy (LC3II/ATG7/p62/CK18) and improved histology.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-13T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Sameeah Mejbel Hamad Algenabi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anwar Nather Seiwan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Maha Hussein Hashem Sabra</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Doaa I. Mohamed</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lobna Fouad Abd ElAziz Bassyouni</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Dalia Alaa El-Din Aly El-Waseef</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Samar F. Ezzat</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Omnyah A. El-Kharashi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hanaa F. Abd El-Kareem</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hyfa A. Alzahrani</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Fawzyah Obeedallah Albaldi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ahmed Shokry Elharoun</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mansour Altayyar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Amal Fahmy Dawood</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hebatallah H. Abo Nahas</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ahmed Abdel-Salam M. Elmelegy</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00084C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00084C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00084C</link><title>Beyond infection control: exploring the therapeutic potential of antimicrobials in oncology and their synthetic perspectives</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00084C" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00084C, Review Article&lt;/div&gt;&lt;div&gt;Rahul Kumar, Mohd Yeshab Ansari&lt;br/&gt;This review explores the burgeoning potential of antimicrobial agents in oncology, highlighting their roles in reducing infection-related mortality, enhancing therapeutic effectiveness, and improving the overall quality of life in cancer patients.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-18T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Rahul Kumar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohd Yeshab Ansari</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00097E"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00097E</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00097E</link><title>Phenoxyacetic acid scaffold as a platform for dual anticonvulsant and anti-inflammatory drug design</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00097E" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00097E, Research Article&lt;/div&gt;&lt;div&gt;Mohamed K. Elgohary, Mahmoud Abdelrahman Alkabbani, Aya Mohamed Ahmed Ibrahim, Ahmed Elsonbaty, Mayada H. Mohamed, Abdulrahman A. Almehizia, Ahmed M. Naglah, Mohamed Fares, Hatem A. Abdel-Aziz&lt;br/&gt;Neuroinflammation is increasingly recognized as a critical contributor to epileptogenesis and antiepileptic drug resistance, emphasizing the need for multi-target therapeutic strategies.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-10T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed K. Elgohary</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mahmoud Abdelrahman Alkabbani</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Aya Mohamed Ahmed Ibrahim</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ahmed Elsonbaty</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mayada H. Mohamed</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Abdulrahman A. Almehizia</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ahmed M. Naglah</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed Fares</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hatem A. Abdel-Aziz</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00088F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00088F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00088F</link><title>Beyond Acrylamide: A Structure-Guided Investigation of Covalent Warheads in the Development of CDK7 Inhibitors</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00088F, Research Article&lt;/div&gt;&lt;div&gt;Jiaan Shao, Yu Cao, Yiqing  Huang, Yunlong Pan, Jialuo  Mao, Lixin Gao, Jiankang Zhang, Huajian Zhu, Shourong  Liu, Rangxiao Zhuang, Yang  Liu, Yu-Bo Zhou&lt;br/&gt;To achieve covalent CDK7 inhibitors with superior antiproliferative activity and enhanced selectivity, we designed and synthesized a series of covalent CDK7 inhibitors bearing diverse warheads based on the THZ1 scaffold....&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-10T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Jiaan Shao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yu Cao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yiqing  Huang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yunlong Pan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jialuo  Mao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lixin Gao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jiankang Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Huajian Zhu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shourong  Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rangxiao Zhuang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yang  Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yu-Bo Zhou</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01095K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01095K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01095K</link><title>Recent advances towards BACE1 drug discovery and therapeutics design</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01095K, Review Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Saim  Imran, Meera Patel, Meissam Noroozifar, Kagan Kerman&lt;br/&gt;Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and memory loss. A key feature of AD is the accumulation of amyloid beta (Aβ) peptides in the...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-09T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Saim  Imran</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Meera Patel</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Meissam Noroozifar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kagan Kerman</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00217J"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00217J</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00217J</link><title>Bicyclic Monoterpenoid-Based Orthopoxvirus Inhibitors: Design, Synthesis, and Biological Assessment of a Novel Amide Series</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00217J, Research Article&lt;/div&gt;&lt;div&gt;Serafim A Tishchenko, Anastasiya Sokolova, Valeriya V Samsonova, Julia G Pushkareva, Daria E Solomina, Olga I Yarovaya, Nikolay I. Bormotov, Ivan A. Moskalev, Artem Rogachev, Alina Fatyanova, Sophia Borisevich, Olga Serova, Alena Ovchinnikova, Larisa Shishkina, Alexander Agafonov, Artemiy Sergeev, Nariman Salakhutdinov,  Alexander  Sergeev&lt;br/&gt;This study reports the design, synthesis, and comprehensive biological evaluation of a new class of orthopoxvirus inhibitors utilizing natural bicyclic monoterpenoid scaffolds as strategic replacements for synthetic polycyclic cores. A...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-09T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Serafim A Tishchenko</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anastasiya Sokolova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Valeriya V Samsonova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Julia G Pushkareva</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Daria E Solomina</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Olga I Yarovaya</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nikolay I. Bormotov</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ivan A. Moskalev</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Artem Rogachev</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alina Fatyanova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sophia Borisevich</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Olga Serova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alena Ovchinnikova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Larisa Shishkina</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alexander Agafonov</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Artemiy Sergeev</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nariman Salakhutdinov</creator><creator xmlns="http://purl.org/dc/elements/1.1/"> Alexander  Sergeev</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00076B"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00076B</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00076B</link><title>A Comprehensive Study of Novel Pregnenolone-Isoxazole Hybrids as Selective Inducers of Mitochondrial Apoptosis in Breast Cancer Cells</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00076B, Research Article&lt;/div&gt;&lt;div&gt;Victoria  Malakhova, Alexander  Scherbakov, Diana I. Salnikova, Alvina Khamidullina, Danila  Sorokin, Dmitry A. Vasilenko, Elena Chernoburova, Elena Averina, Igor V. Zavarzin, Yulia Volkova&lt;br/&gt;Heterocyclic derivatives of steroids have emerged as promising anticancer agents by concurrently targeting multiple pathways, including apoptosis induction, cell cycle arrest, and mitochondrial dysfunction. Here, we report novel pregnenolone-isoxazole hybrids...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-08T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Victoria  Malakhova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alexander  Scherbakov</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Diana I. Salnikova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alvina Khamidullina</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Danila  Sorokin</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Dmitry A. Vasilenko</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Elena Chernoburova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Elena Averina</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Igor V. Zavarzin</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yulia Volkova</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00013D"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00013D</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00013D</link><title>Triclosan–isatin hybrids as potent anti-proliferative agents inducing S-phase arrest via DNA gyrase inhibition in triple-negative breast cancer</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00013D" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00013D, Research Article&lt;/div&gt;&lt;div&gt; Shekhar, Asif Raza, Sukhmanpreet kaur, Amit Anand, Arun K. Sharma, Vipan Kumar&lt;br/&gt;A series of 1&lt;em&gt;H&lt;/em&gt;-1,2,3-triazole-tethered TCS–isatin hybrid compounds were synthesized and evaluated for their antiproliferative activity against triple-negative breast cancer (TNBC).&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-24T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/"> Shekhar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Asif Raza</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sukhmanpreet kaur</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Amit Anand</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Arun K. Sharma</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vipan Kumar</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00165C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00165C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00165C</link><title>Quinoline/Thiazole Compounds as Selective Acetylcholinesterase Inhibitors: Synthesis and Biological Assessment</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00165C, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Berkant Kurban, Derya Osmaniye, Serkan Levent, Yusuf Ozkay, Zafer Asim Kaplancikli&lt;br/&gt;Acetylcholine (ACh), acetylcholinesterase enzyme (AChE), and AChE inhibition are of great importance in the treatment of neurodegenerative diseases. When it comes to AChE inhibition, FDA-approved AChE inhibitors such as Donepezil...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-07T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Berkant Kurban</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Derya Osmaniye</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Serkan Levent</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yusuf Ozkay</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zafer Asim Kaplancikli</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01173F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01173F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01173F</link><title>Redefining the role of the thiol-based agent N-acetylcysteine in human health and disease and elucidating potential advantages of its amide derivative</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01173F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01173F, Review Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Hui-Qi Qu, Charlly Kao, Hakon Hakonarson&lt;br/&gt;&lt;em&gt;N&lt;/em&gt;-Acetylcysteine amide (NACA) reduces polarity and ionization relative to NAC, improving membrane permeability and intracellular exposure while preserving thiol-mediated redox activity and glutathione support.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-01T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Hui-Qi Qu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Charlly Kao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hakon Hakonarson</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00030D"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00030D</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00030D</link><title>Rational discovery of novel phenylindole-bisamide derivatives as potent P-glycoprotein inhibitors for cancer multidrug resistance</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00030D" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00030D, Research Article&lt;/div&gt;&lt;div&gt;Zhikun Yang, Jiajia Han, Yanhong Yang, Xue Yang, Yijing Du, Zimeng Huang, Leyi Ying, Xin Yu, Yi Hua, Qihao Wu, Xiaozhou Mou, Hong Wang&lt;br/&gt;P-gp-mediated MDR hinders cancer chemotherapy. Our phenylindole-bisamide &lt;strong&gt;l1&lt;/strong&gt; shows potent MDR reversal, low cytotoxicity, broad chemosensitization. It inhibits P-gp efflux and suppresses 3D tumor growth with doxorubicin, a promising P-gp inhibitor.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-09T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Zhikun Yang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jiajia Han</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yanhong Yang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xue Yang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yijing Du</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zimeng Huang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Leyi Ying</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xin Yu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yi Hua</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qihao Wu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xiaozhou Mou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hong Wang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01001B"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01001B</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01001B</link><title>Design, Synthesis, and Biological Evaluation of Quinoline Derivatives as Dual-target Inhibitors of Chitin Synthase and Glucosamine-6-Phosphate Synthase</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01001B, Research Article&lt;/div&gt;&lt;div&gt;Nan Wang, Lige  Liu, Tao Liu, Hong Luo, Yan Long, Xinglong Yang, Youli Zhang, Qinggang Ji&lt;br/&gt;Two series of compounds were designed and synthesized based on a glycine methyl ester-quinoline core scaffold combined with a fragment containing nitrogen using either an isoxazole or a piperidine carboxamide...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-26T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Nan Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lige  Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Tao Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hong Luo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yan Long</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xinglong Yang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Youli Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qinggang Ji</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00148C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00148C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00148C</link><title>Novel zerumbone-amide-triazole hybrids as potential NF-κB pathway inhibitors: design, synthesis, cytotoxicity evaluation, computational studies, and mechanistic insights</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00148C, Research Article&lt;/div&gt;&lt;div&gt;Chinh The Pham, Thi Tham Pham, Lien Thi Vu, Nhung Thi Dao, Loan Thi Thuy Le, Khieu  Thi Tam, Vu Tuan Kien, Cao Thanh Hải, Thanh Phuong Phan, T. T. Thao, Truong Xuan Vuong, Le Thi Lien&lt;br/&gt;A series of fifteen novel zerumbone-amide-triazole hybrids 12a-i and 15a-f were successfully designed and synthesized from azazerumbone II (2) via Click reaction. The cytotoxicity of these derivatives was evaluated against...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-26T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Chinh The Pham</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Thi Tham Pham</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lien Thi Vu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nhung Thi Dao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Loan Thi Thuy Le</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Khieu  Thi Tam</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vu Tuan Kien</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Cao Thanh Hải</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Thanh Phuong Phan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">T. T. Thao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Truong Xuan Vuong</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Le Thi Lien</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01027F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01027F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01027F</link><title>Adamantane-based inhibitors of the influenza A M2 proton channel: structure-based design, biological evaluation, and synthetic approaches</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01027F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01027F, Review Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Marianna Stampolaki, Maria-Eleni Kouridaki, Kyriakos Georgiou, Antonios Kolocouris&lt;br/&gt;Experimental structures and accurate simulations can guide the design and synthesis of adamantanamines that can block AM2 wild-type and mutant AM2-mediated proton conductance.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-23T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Marianna Stampolaki</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Maria-Eleni Kouridaki</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kyriakos Georgiou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Antonios Kolocouris</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00026F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00026F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00026F</link><title>D-Galactose-conjugated pyrimidine thioureas as potent antimicrobial agents: rapid green synthesis, structure-activity relationships and molecular modelling</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00026F, Research Article&lt;/div&gt;&lt;div&gt;Nguyen Dinh Thanh, Vu Ngoc Toan, Ngo  Hong Anh Thu, Nguyen Minh Tri, Duong Ngoc Toan, Hoang Thi Kim Van&lt;br/&gt;A series of D-galactose-conjugated pyrimidine-based thioureas 8a-l was efficiently synthesized using an environmentally benign ionic liquid-microwave protocol. Optimal conditions employing [BMIM][BF4] under microwave irradiation (100 W) afforded excellent yields (up...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-25T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Nguyen Dinh Thanh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vu Ngoc Toan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ngo  Hong Anh Thu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nguyen Minh Tri</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Duong Ngoc Toan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hoang Thi Kim Van</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01109D"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01109D</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01109D</link><title>Exploration of a benzothiophene scaffold for use as adjuvants with β-lactam antibiotics against methicillin-resistant Staphylococcus aureus</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01109D" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01109D, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Monica A. Stefaniak, Vijay S. Gondil, Emily P. Gillis, Ansley M. Nemeth, Allen G. Oliver, Roberta J. Melander, Paul M. Dunman, Christian Melander&lt;br/&gt;Rising antibiotic resistance coupled with diminishing investment in antibiotic development has led to limited treatment options for multi drug-resistant bacterial infections.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-05T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Monica A. Stefaniak</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vijay S. Gondil</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Emily P. Gillis</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ansley M. Nemeth</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Allen G. Oliver</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Roberta J. Melander</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Paul M. Dunman</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Christian Melander</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00841G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00841G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00841G</link><title>The dual functions of a nor-sesquiterpene-triazole derivative against influenza A viruses through the activation of the Nrf2/HO-1 signaling pathway and interaction with hemagglutinin</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00841G" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1735-1748&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00841G, Research Article&lt;/div&gt;&lt;div&gt;Shaofen Zhou, Jingyan Wei, Shixin Li, Jingnan Qiu, Shuaiqi Ma, Jian He&lt;br/&gt;&lt;strong&gt;SF-4&lt;/strong&gt; inhibits influenza virus infection and the excessive inflammatory response resulting from viral infection by inhibiting NF-κB activation and activating the Nrf2/HO-1 pathway.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-27T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Shaofen Zhou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jingyan Wei</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shixin Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jingnan Qiu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shuaiqi Ma</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jian He</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01142F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01142F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01142F</link><title>A halogenated pregnenolone analogue suppresses HepG2 proliferation and induces apoptosis via PPARγ regulation</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01142F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1493-1512&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01142F, Research Article&lt;/div&gt;&lt;div&gt;Shi-Ying Xu, Quan-Xing Liu, Yan Luo, Wu-He Wu, Qing Li, Shang-Gao Liao, Jun-Li Ao, Guo-Bo Xu&lt;br/&gt;Halogenated pregnenolone derivative &lt;strong&gt;20&lt;/strong&gt; exerts potent anti-HepG2 effects by inhibiting proliferation and inducing apoptosis through PPARγ modulation.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-26T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Shi-Ying Xu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Quan-Xing Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yan Luo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wu-He Wu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qing Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shang-Gao Liao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jun-Li Ao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Guo-Bo Xu</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01011J"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01011J</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01011J</link><title>Empowering molecular complexity via biocatalysis: emerging blueprints in the total synthesis of medicinally relevant natural products</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01011J" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1397-1444&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01011J, Review Article&lt;/div&gt;&lt;div&gt;Ram N. Yadav, Sovan Dey, Md. Firoj Hossain, Devalina Ray, Bimal K. Banik, Luciana C. Schmidt, Vandana Singh&lt;br/&gt;Biocatalysis has ascended as a defining force in contemporary total synthesis, furnishing catalytic modalities that deliver molecular complexity with unparalleled chemo-, regio-, and stereo-control.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-23T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Ram N. Yadav</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sovan Dey</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Md. Firoj Hossain</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Devalina Ray</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Bimal K. Banik</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Luciana C. Schmidt</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vandana Singh</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00922G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00922G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00922G</link><title>Integrating green synthesis and liquid–liquid extraction of lidocaine in deep eutectic solvents</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00922G" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1474-1482&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00922G, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Assunta Perri, Leonardo C. Parrotta, Stefania Gencarelli, Roberta Sole, Oana M. Dragostin, Gabriela Guillena, Maria L. Di Gioia&lt;br/&gt;A DES-to-DES process enables one-pot lidocaine synthesis with solvent-free isolation, while eutectic media serve as reaction solvents, extraction agents and formulation platforms, enabling reduced PMI and greener pharmaceutical processing.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-18T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Assunta Perri</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Leonardo C. Parrotta</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Stefania Gencarelli</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Roberta Sole</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Oana M. Dragostin</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Gabriela Guillena</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Maria L. Di Gioia</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01007A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01007A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01007A</link><title>A medicinal chemistry perspective on SIRT3 modulators in disease treatment</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01007A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1347-1368&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01007A, Review Article&lt;/div&gt;&lt;div&gt;Yaoliang Li, Yuqi Bao, Yunxia Cui, Jian Zhang, Mingliang Wang&lt;br/&gt;This review analyzes the structure–activity relationships, mechanisms, and activity of SIRT3 modulators, and discusses future directions like selective design, targeted delivery, and protease-mediated degradation for treating SIRT3-related diseases.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-14T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Yaoliang Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yuqi Bao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yunxia Cui</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jian Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mingliang Wang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00940E"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00940E</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00940E</link><title>Synthesis and biological evaluation of carabrol derivatives</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00940E" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1619-1635&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00940E, Research Article&lt;/div&gt;&lt;div&gt;Haidi Wu, Mengshi Zhao, Shifeng Ren, Xiaodong Mu, Yanqin Lu, Yuji Liang, Jingyong Sun&lt;br/&gt;A carabrol derivative reduces the production of the inflammatory mediator NO in macrophages by inhibiting the expression of iNOS and COX-2.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-06T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Haidi Wu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mengshi Zhao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shifeng Ren</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xiaodong Mu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yanqin Lu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yuji Liang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jingyong Sun</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01038A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01038A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01038A</link><title>Medicinal attributes of nitrogen heterocycles directing aldose reductase selectivity and potency</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01038A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1445-1473&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01038A, Review Article&lt;/div&gt;&lt;div&gt;Anita Kumari, Shyamal Kumar Manna, Kajal Rani, Rupali Kohal, Ghanshyam Das Gupta, Sant Kumar Verma&lt;br/&gt;This review describes the medicinal attributes of nitrogen heterocycles, including SAR and target-interaction studies that guide their selectivity and potency for aldose reductase.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-04T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Anita Kumari</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shyamal Kumar Manna</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kajal Rani</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rupali Kohal</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ghanshyam Das Gupta</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sant Kumar Verma</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00997A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00997A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00997A</link><title>Design, synthesis, and molecular modeling of novel thiazolopyridine-based inhibitors of enoyl acyl carrier protein reductase (InhA) as anti-Mycobacterium tuberculosis agents</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00997A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1586-1599&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00997A, Research Article&lt;/div&gt;&lt;div&gt;Ahmed Sabt, Małgorzata Korycka-Machała, Asmaa F. Kassem, Abdulrahman M. Saleh, Hanaa Farag, Moataz A. Shaldam, Mohamed G. Thabit, Anna Brzostek, Magdalena Kuzioła, Bożena Dziadek, Hoda Atef Abdelsattar Ibrahim, Xinsheng Lei, Jarosław Dziadek, Mohamed A. Abdelrahman&lt;br/&gt;The updated guidelines from the World Health Organization highlight that treatment options for multidrug-resistant tuberculosis (MDR-TB) remain limited due to the scarcity of effective drugs.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-04T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Ahmed Sabt</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Małgorzata Korycka-Machała</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Asmaa F. Kassem</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Abdulrahman M. Saleh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hanaa Farag</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Moataz A. Shaldam</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed G. Thabit</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anna Brzostek</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Magdalena Kuzioła</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Bożena Dziadek</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hoda Atef Abdelsattar Ibrahim</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xinsheng Lei</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jarosław Dziadek</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed A. Abdelrahman</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00738K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00738K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00738K</link><title>3-(Pyridine-3-ylmethylene)chroman-4-one and tetralone derivatives: synthesis, Mycobacterium tuberculosis CYP121A1 enzyme inhibition and antimycobacterial activity vs drug-sensitive and drug-resistant strains</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00738K" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1672-1686&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00738K, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Lama A. Alshabani, Jabril M. Abdali, Alistair K. Brown, Damião Pergentino de Sousa, Sam Willcocks, Amit Kumar, Ahmed Y. G. Alhejaili, D. Fernando Estrada, Claire Simons&lt;br/&gt;Chromanone derivatives displayed strong CYP121A1 binding affinity while the tetralone derivatives were very effective antimycobacterial activity against multidrug resistant &lt;em&gt;Mtb&lt;/em&gt;.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-04T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Lama A. Alshabani</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jabril M. Abdali</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alistair K. Brown</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Damião Pergentino de Sousa</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sam Willcocks</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Amit Kumar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ahmed Y. G. Alhejaili</creator><creator xmlns="http://purl.org/dc/elements/1.1/">D. Fernando Estrada</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Claire Simons</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01177A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01177A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01177A</link><title>Structure–activity landscape of Nurr1 (NR4A2) modulators: medicinal chemistry strategies for neurodegenerative disease intervention</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01177A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1369-1396&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01177A, Review Article&lt;/div&gt;&lt;div&gt;Sahil Jaidka, Ankush Kumar, Thakur Gurjeet Singh, Rohit Bhatia, Rajesh Kumar Singh&lt;br/&gt;Nurr1 modulators show promise for neurodegenerative diseases by improving neuroprotection and suppressing neuroinflammation. This review summarizes scaffold-based SAR and highlights challenges in NR4A selectivity and CNS translation.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-01-29T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Sahil Jaidka</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ankush Kumar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Thakur Gurjeet Singh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rohit Bhatia</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rajesh Kumar Singh</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01081K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01081K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01081K</link><title>Leveraging fragment-based drug discovery to advance 3D scaffolds into potent ligands: application to the histamine H1 receptor</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01081K" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1483-1492&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01081K, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Tom Dekker, Oscar P. J. van Linden, Herman D. Lim, Mabel E. Dekker, Henry F. Vischer, Rob Leurs, Tiffany van der Meer, Maurice C. M. L. Buzink, David J. Hamilton, Barbara Zarzycka, Elwin Janssen, Maikel Wijtmans, Iwan J. P. de Esch&lt;br/&gt;Fragment-based drug discovery enables translation of novel (3D) chemistries into biologically relevant hit matter, as demonstrated by the identification and optimization of a cyclobutane-based 3D fragment into a potent histamine H&lt;small&gt;&lt;sub&gt;1&lt;/sub&gt;&lt;/small&gt; receptor ligand.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-01-29T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Tom Dekker</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Oscar P. J. van Linden</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Herman D. Lim</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mabel E. Dekker</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Henry F. Vischer</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rob Leurs</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Tiffany van der Meer</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Maurice C. M. L. Buzink</creator><creator xmlns="http://purl.org/dc/elements/1.1/">David J. Hamilton</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Barbara Zarzycka</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Elwin Janssen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Maikel Wijtmans</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Iwan J. P. de Esch</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01008J"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01008J</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01008J</link><title>Novel glycine amides, semicarbazides and fluoroallylamines as inhibitors of the amine oxidase vascular adhesion protein-1 (VAP-1)</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01008J" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1709-1728&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01008J, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Timo Pöstges, Jan Kampschulze, Walburga Hanekamp, Marcel Bermúdez, Matthias Lehr&lt;br/&gt;Vascular adhesion protein-1 (VAP-1), also known as copper-containing amine oxidase 3 (AOC3), is an enzyme implicated in the pathogenesis of various diseases.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-01-28T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Timo Pöstges</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jan Kampschulze</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Walburga Hanekamp</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Marcel Bermúdez</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Matthias Lehr</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00944H"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00944H</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00944H</link><title>Structure–activity optimization of N-arylindole GPR52 agonists for enhanced antipsychotic efficacy: design, synthesis, and pharmacological evaluation</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00944H" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1749-1757&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00944H, Research Article&lt;/div&gt;&lt;div&gt;Xiaojie Hu, Qingshan Gu, Qiuyu Xiong, Donglei Chen, Qingkun Wu, Lu Zheng&lt;br/&gt;A series of &lt;em&gt;N&lt;/em&gt;-arylindole GPR52 agonists were developed &lt;em&gt;via&lt;/em&gt; linker, head, and tail optimization, showing moderate to good activity and antipsychotic potential. SAR highlights the importance of balanced flexibility and hydroxyl groups.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-01-27T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Xiaojie Hu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qingshan Gu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qiuyu Xiong</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Donglei Chen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qingkun Wu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lu Zheng</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00980D"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00980D</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00980D</link><title>Synthesis of new trans-ferulic acid derivatives as potential anticancer agents and VEGFR-2 inhibitors</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00980D" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1636-1650&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00980D, Research Article&lt;/div&gt;&lt;div&gt;Asmaa N. Mohie, Mahmoud A. Doheim, Ragab A. El Masry, Ayman M. Gomaa, Rofaida Salem, Haytham O. Tawfik, Wagdy M. Eldehna&lt;br/&gt;By using –OH blocking, seven TFA derivatives were created. Compound &lt;strong&gt;4e&lt;/strong&gt; regulated AFP, BCL-2, caspase-3, and P53, inhibited VEGFR-2 in docking, and exhibited the maximum cytotoxicity against HepG2, Hep3B, and Huh7 with a safe profile.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-01-22T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Asmaa N. Mohie</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mahmoud A. Doheim</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ragab A. El Masry</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ayman M. Gomaa</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rofaida Salem</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Haytham O. Tawfik</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wagdy M. Eldehna</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00887E"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00887E</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00887E</link><title>Endoperoxide delivered singlet oxygen: the future of PDT, without light or oxygen</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00887E" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1729-1734&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00887E, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Wanwan Wang, Lei Wang, Rensong Sun, Xiao Qian, Ziang Liu, Engin U. Akkaya&lt;br/&gt;Chemically generated singlet oxygen &lt;em&gt;via&lt;/em&gt; cycloreversion reaction of aromatic endoperoxides is poised to evolve into a highly promising therapeutic protocol.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-01-17T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Wanwan Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lei Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rensong Sun</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xiao Qian</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ziang Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Engin U. Akkaya</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00992H"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00992H</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00992H</link><title>2,5-Diazabicyclo[2.2.1]heptane in medicinal chemistry: a treasure trove of therapeutic opportunities</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00992H" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1299-1346&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00992H, Review Article&lt;/div&gt;&lt;div&gt;Pranav Kumar Ambast, Saumya Kapoor, Rudradip Das, Deep Rohan Chatterjee, Amit Shard&lt;br/&gt;2,5-Diazabicyclo[2.2.1]heptane (2,5-DBH) is a conformationally rigid bicyclic diamine and a privileged scaffold in medicinal chemistry, enabling diverse synthetic modifications and broad therapeutic applications across multiple disease areas.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-01-16T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Pranav Kumar Ambast</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Saumya Kapoor</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rudradip Das</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Deep Rohan Chatterjee</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Amit Shard</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00830A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00830A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00830A</link><title>Discovery of RP-37 analogues as potent, selective irreversible inhibitors targeting DNA polymerase theta (POLθ)</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00830A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1694-1708&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00830A, Research Article&lt;/div&gt;&lt;div&gt;Zhenwei Wang, Mengyuan Qiu, Deming Liu, Yanzhen Yu, Dongyan Gu, FengMin Zhang, Rong Sheng&lt;br/&gt;Enzymatic IC&lt;small&gt;&lt;sub&gt;50&lt;/sub&gt;&lt;/small&gt; = 1.54 nM (POLθ polymerase domain). Cellular IC&lt;small&gt;&lt;sub&gt;50&lt;/sub&gt;&lt;/small&gt; = 1.16 μM (DLD-1 BRCA2&lt;small&gt;&lt;sup&gt;−/−&lt;/sup&gt;&lt;/small&gt;; ∼5-fold enhancement). Sustained target engagement &lt;em&gt;via&lt;/em&gt; irreversible inhibition.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-01-16T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Zhenwei Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mengyuan Qiu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Deming Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yanzhen Yu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Dongyan Gu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">FengMin Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rong Sheng</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00910C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00910C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00910C</link><title>Exploring pyrazoline-thiophene hybrids as CDK2 inhibitors: synthesis, mechanism, biological studies, and computational insights</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00910C" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1651-1671&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00910C, Research Article&lt;/div&gt;&lt;div&gt;Heba M. Abosalim, Tarek F. El-Moselhy, Nabaweya Sharafeldin, Mohamed S. Nafie, Mohamed K. Diab, Mervat H. El-Hamamsy, Haytham O. Tawfik&lt;br/&gt;Novel pyrazoline-linked thiophenes were synthesized as anticancer agents. Lead compound &lt;strong&gt;4p&lt;/strong&gt; showed sub-micromolar cytotoxicity, induced CDK2-mediated apoptosis and cell-cycle arrest, and reduced tumor burden &lt;em&gt;in vivo&lt;/em&gt; with low toxicity.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-01-15T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Heba M. Abosalim</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Tarek F. El-Moselhy</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nabaweya Sharafeldin</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed S. Nafie</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed K. Diab</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mervat H. El-Hamamsy</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Haytham O. Tawfik</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01116G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01116G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01116G</link><title>Investigating the role of cytochrome bd oxidases in the antibacterial activity of madecassic acid and derivatives thereof</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01116G" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1513-1520&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01116G, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Samantha A. Henry, Geraud N. Sansom, Thao Thi Phuong Tran, Ryan A. Boughton, Guy Joiner, Calum M. Webster, H. Ireshika C. de Silva, Michelle D. Garrett, Christopher J. Serpell, Gary K. Robinson, Mark Shepherd&lt;br/&gt;Madecassic acid is found to have activity against cytochrome proteins found only in bacteria, offering a new route to antibiotics.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-01-13T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Samantha A. Henry</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Geraud N. Sansom</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Thao Thi Phuong Tran</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ryan A. Boughton</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Guy Joiner</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Calum M. Webster</creator><creator xmlns="http://purl.org/dc/elements/1.1/">H. Ireshika C. de Silva</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Michelle D. Garrett</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Christopher J. Serpell</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Gary K. Robinson</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mark Shepherd</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00839E"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00839E</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00839E</link><title>Oxyprenyl–chalcones as antibacterial hits: design of experiments-optimized synthesis, antibacterial evaluation, early drug-like profiling and biodegradability prediction</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00839E" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1573-1585&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00839E, Research Article&lt;/div&gt;&lt;div&gt;Ludovica Marotta, Francesca Maria Pia Rita Giammarino, Brondon Brandly Senenou Tambou, Valeria Tudino, Stefania Butini, Lorenza Broccardo, Sacha Michèle Idriss Cancade, Jean-Denis Docquier, Federica Perego, Nicoletta Basilico, Lorenzo Raffellini, Sheraz Gul, Gabriele Carullo, Sandra Gemma, Giuseppe Campiani&lt;br/&gt;The escalating threat of antimicrobial resistance (AMR) compels the development of novel antibiotics with broad spectrum activity and environmentally responsible degradation profiles.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-01-12T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Ludovica Marotta</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Francesca Maria Pia Rita Giammarino</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Brondon Brandly Senenou Tambou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Valeria Tudino</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Stefania Butini</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lorenza Broccardo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sacha Michèle Idriss Cancade</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jean-Denis Docquier</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Federica Perego</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nicoletta Basilico</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lorenzo Raffellini</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sheraz Gul</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Gabriele Carullo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sandra Gemma</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Giuseppe Campiani</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00678C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00678C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00678C</link><title>Efficient log P determination by automated, spatially encoded 19F NMR spectroscopy</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00678C" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1550-1558&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00678C, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Susanna H. Wood, Fiona Gordon, Robin S. Stein, Mark J. Howard, John A. Parkinson&lt;br/&gt;A method for measuring log &lt;em&gt;P&lt;/em&gt; of fluorinated molecules by &lt;small&gt;&lt;sup&gt;19&lt;/sup&gt;&lt;/small&gt;F NMR under full instrument automation. Placing an advanced NMR technique in the hands of synthetic chemists for simple, efficient data acquisition.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-01-12T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Susanna H. Wood</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Fiona Gordon</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Robin S. Stein</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mark J. Howard</creator><creator xmlns="http://purl.org/dc/elements/1.1/">John A. Parkinson</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00874C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00874C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00874C</link><title>Design and optimization of simplified inhibitors targeting Escherichia coli and Klebsiella pneumoniae IspE</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00874C" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1687-1693&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00874C, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Danica J. Walsh, Rawia Hamid, Tim Giele, Norbert Reiling, Matthias Rottmann, Mostafa M. Hamed, Anna K. H. Hirsch&lt;br/&gt;Simplified amide IspE inhibitors restore potency against &lt;em&gt;Klebsiella pneumoniae&lt;/em&gt; and &lt;em&gt;Escherichia coli&lt;/em&gt;, offering synthetically accessible antibacterial hits.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-01-08T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Danica J. Walsh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rawia Hamid</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Tim Giele</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Norbert Reiling</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Matthias Rottmann</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mostafa M. Hamed</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anna K. H. Hirsch</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01040C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01040C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01040C</link><title>A dialogue on innovation in anticancer drug discovery</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01040C" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1246-1251&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01040C, Opinion&lt;/div&gt;&lt;div&gt;Susanta Samajdar&lt;br/&gt;From cytotoxic agents to proximity-inducing modalities and advanced drug conjugates.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-01-07T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Susanta Samajdar</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00928F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00928F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00928F</link><title>CNS penetrant TEAD1,2,4 inhibitor MSC-4070 derived from phenotypic screening hit optimization</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00928F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1559-1572&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00928F, Research Article&lt;/div&gt;&lt;div&gt;Timo Heinrich, Carl Petersson, Jakub Gunera, Alessia Gambardella, Daniel Schwarz, Sakshi Garg, Heike Schilke, Thomas Weitzel, Christian Kolb, Uwe Anlauf, Vivian Reither, Corinna Rettig, Beate Opelt, Andrea Delp, Nicole Wildner, Pedro M. F. Sousa, Filipe Freire, Tiago M. Bandeiras, Dirk Wienke&lt;br/&gt;&lt;em&gt;N&lt;/em&gt;-Methylation decreased efflux in the Caco-2 assay without compromising activity, yielding the brain-penetrant TEAD inhibitor &lt;strong&gt;MSC-4070&lt;/strong&gt;.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-01-07T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Timo Heinrich</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Carl Petersson</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jakub Gunera</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alessia Gambardella</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Daniel Schwarz</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sakshi Garg</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Heike Schilke</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Thomas Weitzel</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Christian Kolb</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Uwe Anlauf</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vivian Reither</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Corinna Rettig</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Beate Opelt</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Andrea Delp</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nicole Wildner</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Pedro M. F. Sousa</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Filipe Freire</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Tiago M. Bandeiras</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Dirk Wienke</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00950B"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00950B</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00950B</link><title>Inhibitors of type II NADH-dehydrogenase, cytochrome bd oxidase, and ATP synthase for anti-tubercular response</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00950B" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1271-1288&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00950B, Review Article&lt;/div&gt;&lt;div&gt;Pallavi Saha, Mohit Kumar, Deepak K. Sharma&lt;br/&gt;The identification of novel anti-tubercular agents capable of eliciting lethal responses against drug-resistant tuberculosis is critically needed to address the escalating mortality from tuberculosis.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-01-05T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Pallavi Saha</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohit Kumar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Deepak K. Sharma</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00867K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00867K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00867K</link><title>Recent progress of METTL3 inhibitors for cancer therapeutics: design, optimization and potential applications</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00867K" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1289-1298&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00867K, Review Article&lt;/div&gt;&lt;div&gt;Yun Zhang, Mengxiang Quan, Qinlan Chen, Hongdi Han, Xianling Zhang, Xiangwei Xu, Zunyuan Wang&lt;br/&gt;METTL3 plays an important role in AML and other cancers. This review summarized the strategies for discovering and optimizing METTL3 inhibitors, and looked forward to the potential application prospects of METTL3 inhibitors in clinical practice.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-01-02T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Yun Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mengxiang Quan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qinlan Chen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hongdi Han</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xianling Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xiangwei Xu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zunyuan Wang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00890E"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00890E</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00890E</link><title>Novel isoxazolone derivatives as acetylcholinesterase inhibitors: design, synthesis, in silico and in vitro evaluation</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00890E" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1600-1618&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00890E, Research Article&lt;/div&gt;&lt;div&gt;Nitasha Gohar, Adil Saeed, Muzaffar Abbas, Sana Ayaz, Iqra Zulfiqar, Syed Muzzammil Masaud, Humaira Nadeem&lt;br/&gt;Acetylcholinesterase (AChE) plays a pivotal role in Alzheimer's disease by accelerating acetylcholine breakdown, leading to cognitive decline.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2025-12-30T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Nitasha Gohar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Adil Saeed</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Muzaffar Abbas</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sana Ayaz</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Iqra Zulfiqar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Syed Muzzammil Masaud</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Humaira Nadeem</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00970G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00970G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00970G</link><title>Targeted degradation of Pin1 by an antagonistic peptide enhances gemcitabine therapy in pancreatic cancer</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00970G" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1537-1549&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00970G, Research Article&lt;/div&gt;&lt;div&gt;Mengting Chen, Xiangyu Chu, Haipeng Zhao, Lilusi Ma, Jie Meng, Yanlian Yang, Qiaojun Fang, Xiaocui Fang, Chen Wang&lt;br/&gt;PIPWF peptide binds to the Pin1 protein through multi-site interactions, thereby inducing its conformational change and leading to subsequent degradation.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2025-12-30T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Mengting Chen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xiangyu Chu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Haipeng Zhao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lilusi Ma</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jie Meng</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yanlian Yang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qiaojun Fang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xiaocui Fang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Chen Wang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00935A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00935A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00935A</link><title>Ferrocenyl ferroptosis inducers as an emerging class of anticancer agents: a mini review</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00935A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1252-1270&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00935A, Review Article&lt;/div&gt;&lt;div&gt;Mateusz Klarek, Aryan Gautam, Konrad Kowalski&lt;br/&gt;Ferroptosis is one of the regulated cell death pathways. Molecular mechanisms underlying ferroptosis involve iron-dependent lipid peroxidation, which results in cell-deleterious membrane damage.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2025-12-29T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Mateusz Klarek</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Aryan Gautam</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Konrad Kowalski</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00897B"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00897B</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00897B</link><title>Kupffer cell M2-like polarization increases liver metastatic burden via the uptake of exosomal KRAS mutant protein from hypoxic colorectal carcinoma cells</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00897B" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1521-1536&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00897B, Research Article&lt;/div&gt;&lt;div&gt;Yu You, Zhihao Feng, Jiao Lu, Jie Xu, Ke You, Fuyao Liu, Tianzhu Wu, Hua Song, Zuojin Liu&lt;br/&gt;Kupffer cell M2-like polarization driven by exosomal mutant KRAS &lt;em&gt;via&lt;/em&gt; AKT signaling is a key factor in colorectal cancer liver metastasis.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2025-12-20T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Yu You</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zhihao Feng</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jiao Lu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jie Xu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ke You</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Fuyao Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Tianzhu Wu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hua Song</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zuojin Liu</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00900F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00900F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00900F</link><title>From bolinaquinone, a marine hydroxyquinone sesquiterpene, to naphthoquinones with clathrin inhibitory effects</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00900F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00900F, Research Article&lt;/div&gt;&lt;div&gt;Nicholas S. O'Brien, Azadeh Ghods, Jing Xue, Mary J. Garson, Ken W. L. Yong, Jennette A. Sakoff, Jayne Glibert, Megan Chircop, Uwe Fink, Volker Haucke, Phillip J. Robinson, Adam McCluskey&lt;br/&gt;Bolinaquinone (&lt;strong&gt;1&lt;/strong&gt;) is cited as a clathrin inhibitor; applying a DFT approach, naphthoquinones with similar electronic properties were designed and shown to be potent inhibitors of the clathrin N-terminal domain–amphiphysin interaction, &lt;em&gt;e.g.&lt;/em&gt; &lt;strong&gt;23&lt;/strong&gt;.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2025-12-30T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Nicholas S. O'Brien</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Azadeh Ghods</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jing Xue</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mary J. Garson</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ken W. L. Yong</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jennette A. Sakoff</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jayne Glibert</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Megan Chircop</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Uwe Fink</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Volker Haucke</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Phillip J. Robinson</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Adam McCluskey</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01046B"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01046B</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01046B</link><title>Design, synthesis and biological evaluation of benzoyl hydrazone derivatives as anticancer agents inducing ROS-associated mitochondrial apoptosis</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01046B" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01046B, Research Article&lt;/div&gt;&lt;div&gt;Rongbin Wei, Xin Wang, Yamin Ding, Suting Zhu, Richmond Kwame Frimpong Asiedu, Muzi Li, Haitao Qian, Yifei Gu, Bailing Jiang&lt;br/&gt;Compound &lt;strong&gt;Q-11&lt;/strong&gt; shows potent nanomolar antiproliferative activity in gastric cancer cells and induces ROS accumulation, mitochondrial dysfunction and cytoskeletal disruption.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-23T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Rongbin Wei</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xin Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yamin Ding</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Suting Zhu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Richmond Kwame Frimpong Asiedu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Muzi Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Haitao Qian</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yifei Gu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Bailing Jiang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00091F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00091F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00091F</link><title>The effects of bioisostere substitution on the antimicrobial and physicochemical properties of supramolecular self-associating amphiphiles</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00091F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00091F, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Pinky K. Naicker, Mariam Yacoub, Lisa J. White, Dominick E. Balderston, Perry A. Hailey, J. Mark Sutton, Charlotte K. Hind, Jennifer R. Hiscock&lt;br/&gt;The use of bioisosteres enhances the antimicrobial activity for a range of supramolecular self-associating amphiphiles.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-23T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Pinky K. Naicker</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mariam Yacoub</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lisa J. White</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Dominick E. Balderston</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Perry A. Hailey</creator><creator xmlns="http://purl.org/dc/elements/1.1/">J. Mark Sutton</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Charlotte K. Hind</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jennifer R. Hiscock</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01098E"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01098E</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01098E</link><title>Extending the architecture of bolaamphiphilic disinfectants: an investigation of octenidine and isooctenidine analogs</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01098E" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01098E, Research Article&lt;/div&gt;&lt;div&gt;Danielle E. Talbot, Caroline M. Casey, Elise L. Bezold, Kelsi Membrino, Alina Y. Muldagaliyeva, William M. Wuest, Kevin P. C. Minbiole&lt;br/&gt;Octenidine and isooctenidine are equally potent disinfectant architectures, capitalizing on a bolaamphiphilic structure to confer significant activity to two dozen QACs tested against a panel of gram positive, gram negative, and resistant bacteria.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-04T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Danielle E. Talbot</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Caroline M. Casey</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Elise L. Bezold</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kelsi Membrino</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alina Y. Muldagaliyeva</creator><creator xmlns="http://purl.org/dc/elements/1.1/">William M. Wuest</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kevin P. C. Minbiole</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01174D"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01174D</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01174D</link><title>New series of pentamidine-based 1,2,3-triazole-diaryl-hydrazones: design, synthesis, and evaluation of their leishmanicidal activity and mechanism of action against Leishmania (L.) amazonensis</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01174D" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01174D, Research Article&lt;/div&gt;&lt;div&gt;Patrícia F. Espuri Sepini, Vanessa Silva Gontijo, Laiane Mota Tavares, Leonardo Maciel Souza, Thalles H. F. Souza, Dyecika S. Couto, Juliana B. Nunes, Catarina Azevedo Ribeiro, Sara M. Mendonça da Silva Cravo, Bruno Zavan, Marina A. Alves, Hygor M. R. Souza, Marisa Ionta, Maria Emília Sousa, Eduardo F. Peloso, Marcos J. Marques, Claudio Viegas Jr.&lt;br/&gt;New series of pentamidine-based 1,2,3-triazole-diaryl-hydrazones was designed, synthesized, and evaluated against &lt;em&gt;L. amazonensis&lt;/em&gt;, with &lt;strong&gt;PQM-150&lt;/strong&gt; as the most potent multifunctional compound.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-27T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Patrícia F. Espuri Sepini</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vanessa Silva Gontijo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Laiane Mota Tavares</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Leonardo Maciel Souza</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Thalles H. F. Souza</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Dyecika S. Couto</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Juliana B. Nunes</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Catarina Azevedo Ribeiro</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sara M. Mendonça da Silva Cravo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Bruno Zavan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Marina A. Alves</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hygor M. R. Souza</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Marisa Ionta</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Maria Emília Sousa</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Eduardo F. Peloso</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Marcos J. Marques</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Claudio Viegas Jr.</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01140J"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01140J</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01140J</link><title>Verbenone-based selenophene derivatives as potential anti-cancer agents: synthesis and biological evaluation in 2D and 3D A549 cell models</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01140J" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01140J, Research Article&lt;/div&gt;&lt;div&gt;Jiale Han, Wei Shi, Min Hu, Wei Liu, Hongmei Wu, Biao Xiong, Xiaodong Qiu, Yunyun Wang&lt;br/&gt;Compound &lt;strong&gt;2R&lt;/strong&gt;, a verbenone–selenophene hybrid, selectively inhibits A549 cells &lt;em&gt;via&lt;/em&gt; ROS-mediated mitochondrial dysfunction, apoptosis and G0/G1 arrest, with efficacy confirmed in a 3D tumor spheroid model.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-11T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Jiale Han</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wei Shi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Min Hu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wei Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hongmei Wu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Biao Xiong</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xiaodong Qiu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yunyun Wang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01086A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01086A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01086A</link><title>Design and biological evaluation of triagonist GLP-1R/GCGR/GIPR peptides as potential therapeutic agents for diabetes and obesity</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01086A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01086A, Research Article&lt;/div&gt;&lt;div&gt;Iwona Kalinowska, Alicja Gawalska, Paulina Kasprzycka, Michał Stępniewski, Piotr Rózga, Aneta Pałka, Andrii Shubin, Katarzyna Bukato, Marlena Gałązka, Ewa Burchard, Paulina Zielińska-Świder, Albert Jaworski, Marcin Feder&lt;br/&gt;Rational design and molecular modelling enabled the development of potent GLP-1/GIP/GCGR triagonists with robust &lt;em&gt;in vitro&lt;/em&gt; activity and efficacy comparable to established incretin agonists.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-19T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Iwona Kalinowska</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alicja Gawalska</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Paulina Kasprzycka</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Michał Stępniewski</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Piotr Rózga</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Aneta Pałka</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Andrii Shubin</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Katarzyna Bukato</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Marlena Gałązka</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ewa Burchard</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Paulina Zielińska-Świder</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Albert Jaworski</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Marcin Feder</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00057F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00057F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00057F</link><title>Pharmacological landscape of carbolines: a holistic view</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00057F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00057F, Review Article&lt;/div&gt;&lt;div&gt;Yao Zhang, Fule Wu, Muneeb Ur Rehman, Sihui Long&lt;br/&gt;This review comprehensively explores the design, synthesis, and pharmacological activities of carboline isomers reported between 2000 and 2025, with a particular emphasis on their key bioactivities, encompassing anticancer, neuroprotective, antiparasitic, and antimicrobial.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-02T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Yao Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Fule Wu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Muneeb Ur Rehman</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sihui Long</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01138H"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01138H</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01138H</link><title>Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinoline-O-carbamate derivatives as AChE/MAO-B dual inhibitors for the treatment of Alzheimer's disease</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01138H" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01138H, Research Article&lt;/div&gt;&lt;div&gt;Wenling Fu, Keren Wang, Hongsong Chen, Taoyi Liu, Xiaojuan Liu, Qishun Jin, Zhenghuai Tan, Wu Dong, Wenmin Liu, Zhipei Sang&lt;br/&gt;Based on the MTDL strategy, a dual AChE/MAO-B inhibitor &lt;strong&gt;3c&lt;/strong&gt; was obtained. &lt;strong&gt;3c&lt;/strong&gt; presented good BBB permeability and significant efficacy &lt;em&gt;in vivo&lt;/em&gt;.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-27T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Wenling Fu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Keren Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hongsong Chen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Taoyi Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xiaojuan Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qishun Jin</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zhenghuai Tan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wu Dong</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wenmin Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zhipei Sang</creator></item></channel></rss>